RxDoctor Payments Data

Richard Cole, MD

Family Medicine · Stuart, VANPI 1972500668

Payments from drug & device makers

$8,776in general payments, 2019–2025

Across 555 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$971
  • Pfizer$720
  • AstraZeneca$720
  • Amgen$331
  • Johnson & Johnson$265
  • plus $4K from 50 others

What the payments were for

  • Food & beverage$8,752100%
  • Education$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,776 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$63,142
Medicare patients
374
Services billed
2,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban337$143,505
BetaseronInterferon Beta-1b12$123,210
OzempicSemaglutide104$114,609
XareltoRivaroxaban200$87,341
FarxigaDapagliflozin Propanediol220$79,430
JardianceEmpagliflozin153$74,059
RexultiBrexpiprazole74$73,452
LinzessLinaclotide116$69,737
Imatinib Mesylate14$53,839
XifaxanRifaximin40$53,020
Breztri AerosphereBudesonide/Glycopyr/Formoterol61$51,295
EntrestoSacubitril/Valsartan97$50,507
TezspireTezepelumab-Ekko11$47,175
JanuviaSitagliptin Phosphate98$44,073
Trelegy ElliptaFluticasone/Umeclidin/Vilanter77$43,927

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Tezspire, Lokelma$720$189,109322 claims
PfizerEliquis$720$143,505337 claims
AbbVieLinzess, Creon, Ubrelvy, Restasis$1,524$135,149181 claims
BayerBetaseron$147$123,21012 claims
Novo NordiskOzempic$971$114,609104 claims
Johnson & JohnsonXarelto, Invokana$265$105,206217 claims
Boehringer IngelheimJardiance, Combivent Respimat$144$100,050190 claims
GSKTrelegy Ellipta, Shingrix, Arexvy, Anoro Ellipta$242$95,689268 claims
Otsuka America Pharmaceutical, Inc.Rexulti$177$73,45274 claims
MerckJanuvia, Lagevrio (Eua)$130$56,858112 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$146$53,02040 claims
NovartisEntresto$198$50,50797 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Stuart

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →